Description

NSE announces listing of Invicta Diagnostic Limited equity shares on EMERGE SME Platform effective December 08, 2025 with symbol INVICTA in Trade for Trade Surveillance Segment.

Summary

NSE has admitted Invicta Diagnostic Limited’s equity shares for trading on the EMERGE SME Platform effective December 08, 2025. The stock will trade under symbol INVICTA in Series ‘ST’ (Trade for Trade Surveillance Segment with Settlement Type ‘W’) and will subsequently shift to Series ‘SM’ (Normal Rolling Segment). The IPO issue price is Rs. 85 per share with face value of Rs. 10.

Key Points

  • Symbol: INVICTA
  • ISIN: INE0XJ501010
  • Face Value: Rs. 10/-
  • Issue Price: Rs. 85/- per share
  • Total Securities: 12,571,973 equity shares
  • Market Lot: 1,600 equity shares
  • Trading Series: ST (Trade for Trade Surveillance Segment - Settlement Type ‘W’), to be shifted to SM later
  • Market Type: Continuous Market with pre-open session for IPO category
  • Market Maker: Nikunj Stock Brokers Limited
  • Maximum Permissible Spread: Within 10%
  • Distinctive Number Range: 1 to 12,571,973

Regulatory Changes

No regulatory changes. Listing follows existing SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012 for SME IPO listings.

Compliance Requirements

  • Members must use designated security code for trading
  • Trading must be in specified lot size of 1,600 equity shares
  • Security will participate in pre-open session for IPO category as per SEBI guidelines
  • Trading follows Exchange Circular No. NSE/CMTR/37202 dated March 14, 2018
  • Lock-in details as per Annexure I (specific details not provided in main circular)

Important Dates

  • Circular Date: December 05, 2025
  • Listing/Trading Start Date: December 08, 2025
  • Financial Year: April 2025 - March 2026

Impact Assessment

Limited market impact as this is a small-cap SME listing on EMERGE platform. The Trade for Trade Surveillance Segment classification indicates higher risk monitoring. With market lot of 1,600 shares at Rs. 85 per share (Rs. 1,36,000 minimum investment), accessibility is limited to specific investor segments. Market maker arrangement ensures liquidity support. Primary impact is for IPO applicants and SME segment traders.

Impact Justification

Standard SME IPO listing on EMERGE platform with limited market impact, relevant primarily to IPO investors and market makers